title: Prevalence of atopic diseases in patients with sarcoidosis.
abstract: It remains unclear whether atopy is associated with the occurrence of sarcoidosis or affects its severity. The purpose of this study was to compare the lifetime prevalence of atopic eczema, asthma, and hay fever in sarcoidosis patients with controls and to assess whether atopy influences the severity of sarcoidosis. The prevalence of atopic disorders assessed with a validated postal questionnaire in sarcoidosis patients with pulmonary, uveitis, and cutaneous sarcoidosis was compared with that of their domestic partners in a case-control study. The serological parameters, the pulmonary function tests, and the high-resolution computed tomography (HRCT) scans of atopic and nonatopic sarcoidosis patients were compared in a nested cohort. Multivariate logistic regression models were used to calculate the odds ratios (ORs) and the 95% confidence intervals (CIs). Two hundred twenty-five sarcoidosis patients and 177 controls were included. The prevalences of atopic eczema, asthma, and hay fever were comparable between patients and controls (12.4% versus 12.4%, 5.3% versus 5.6%, and 16.9% versus 15.8%, respectively). After adjusting for gender and ethnicity, those with sarcoidosis and a history of atopic eczema were significantly less likely to have uveitis (OR, 0.30; 95% CI, 0.13-0.71). Within the sarcoidosis cohort, the distributions of serological markers, the lung function tests, and the HRCT scans were similar between atopic and nonatopic patients. Atopy is not associated with the occurrence of sarcoidosis, but atopic eczema may decrease the likelihood of eye involvement.
authors.affiliation: Department of Dermatology and Venerology, Erasmus Medical Center, Rotterdam, The Netherlands.
authors.forename: Enes
authors.initials: E
authors.lastname: Hajdarbegovic
authors.forename: Lieke
authors.initials: L
authors.lastname: Kamphuis
authors.forename: Jan
authors.initials: J
authors.lastname: van Laar
authors.forename: Martin
authors.initials: M
authors.lastname: van Hagen
authors.forename: Tamar
authors.initials: T
authors.lastname: Nijsten
authors.forename: Bing
authors.initials: B
authors.lastname: Thio
mesh_terms: D000328:Adult; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D015995:Prevalence; D012507:Sarcoidosis / Q000150:complications* / Q000175:diagnosis; D017565:Sarcoidosis, Pulmonary / Q000150:complications / Q000175:diagnosis; D057566:Self Report